Gene Polymorphisms and Signaling Defects

作者: Christine Mannhalter , Michael Poteser , Klaus Groschner

DOI: 10.1007/978-3-7091-1334-9_4

关键词: Single-nucleotide polymorphismBiologyIdentification (biology)Computational biologyCandidate geneGenetic linkageGenetic variationPreventive healthcareGenotypingGenetic variability

摘要: Understanding heritability of cardiovascular risk is a key issue in preventive medicine and particular importance for the development cost-efficient strategies to preserve health. Recent progress genotyping technologies enabled detailed insight into human genetic variability. Linkage analysis genome-wide association screens have complemented candidate gene studies uncover large array variations associated with pathologies. For majority identified polymorphisms, clinical impact as yet unclear available information still limited value prediction. However, discoveries greatly improved our understanding pathophysiological principles. The identification novel molecular players target structures contributed significantly therapeutic progress. In this chapter we aim present an overview on polymorphisms genes proven or at least convincingly suggested causal relation secondary factors and/or phenotypes. Special attention will be paid functional consequences variations. Many ­polymorphisms that are causally involved pathogenesis dysfunction impair cellular signaling processes may turn affect regulatory networks. Unraveling mechanisms link variability pathological phenotypes rather early stage. We here selection these discuss their significance.

参考文章(253)
Alan T Nurden, Polymorphisms of Human Platelet Membrane Glycoproteins: Structure and Clinical Significance Thrombosis and Haemostasis. ,vol. 74, pp. 345- 351 ,(1995) , 10.1055/S-0038-1642700
Robert A. S. Ariëns, Helen Philippou, Chandrasekaran Nagaswami, John W. Weisel, David A. Lane, Peter J. Grant, The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure Blood. ,vol. 96, pp. 988- 995 ,(2000) , 10.1182/BLOOD.V96.3.988
Kevin R Siebenlist, David A Meh, Michael W Mosesson, None, Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin Thrombosis and Haemostasis. ,vol. 86, pp. 1221- 1228 ,(2001) , 10.1055/S-0037-1616055
Anna M. Kucharska-Newton, Keri L. Monda, Stephen Campbell, Patrick T. Bradshaw, Lynne E. Wagenknecht, Eric Boerwinkle, Bruce A. Wasserman, Gerardo Heiss, Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology. The Atherosclerosis Risk in Communities (ARIC) Study Atherosclerosis. ,vol. 216, pp. 151- 156 ,(2011) , 10.1016/J.ATHEROSCLEROSIS.2011.01.038
David Altshuler, Joel N. Hirschhorn, Mia Klannemark, Cecilia M. Lindgren, Marie-Claude Vohl, James Nemesh, Charles R. Lane, Stephen F. Schaffner, Stacey Bolk, Carl Brewer, Tiinamaija Tuomi, Daniel Gaudet, Thomas J. Hudson, Mark Daly, Leif Groop, Eric S. Lander, The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics. ,vol. 26, pp. 76- 80 ,(2000) , 10.1038/79216
Jeanine Houwing-Duistermaat, Hans van Houwelingen, Jeroen Eikenboom, Rogier Bertina, Frits Rosendaal, Pieter Kamphuisen, Familial clustering of factor VIII and von Willebrand factor levels. Thrombosis and Haemostasis. ,vol. 79, pp. 323- 327 ,(1998) , 10.1055/S-0037-1614985
Jean-Jacques Schott, Connie Alshinawi, Florence Kyndt, Vincent Probst, Theo M. Hoorntje, Miriam Hulsbeek, Arthur A.M. Wilde, Denis Escande, Marcel M.A.M. Mannens, Hervé Le Marec, Cardiac conduction defects associate with mutations in SCN5A. Nature Genetics. ,vol. 23, pp. 20- 21 ,(1999) , 10.1038/12618
Niels H. Gehring, Ute Frede, Gabriele Neu-Yilik, Patrick Hundsdoerfer, Barbara Vetter, Matthias W. Hentze, Andreas E. Kulozik, Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nature Genetics. ,vol. 28, pp. 389- 392 ,(2001) , 10.1038/NG578